ISU Abxis Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ISU Abxis Company Limited with three other
companies in this sector in South Korea:
Viromed Company Ltd
sales of 7.70 billion Korean Won [US$6.55 million]
Cellumed Co Ltd
(17.73 billion Korean Won [US$15.09 million]
Tego Science Inc
(7.49 billion Korean Won [US$6.38 million]
ISU Abxis Company Limited reported sales of 11.47 billion Korean Won (US$9.76 million)
December of 2015.
increase of 61.6%
versus 2014, when the company's sales were 7.10 billion Korean Won.
Sales of Antibody Medicine saw an increase
80.5% in 2015, from
6.33 billion Korean Won to 11.42 billion Korean Won.
Not all segments of ISU Abxis Company Limited experienced an increase in sales in 2015:
sales of Other fell 46.1% to 50.30 million Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).